Barclays’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-571,990
Closed -$3.34M 4568
2022
Q4
$3.34M Buy
571,990
+119,236
+26% +$696K ﹤0.01% 1337
2022
Q3
$3.03M Buy
452,754
+75,341
+20% +$505K ﹤0.01% 1384
2022
Q2
$1.59M Buy
377,413
+333,759
+765% +$1.41M ﹤0.01% 1739
2022
Q1
$147K Hold
43,654
﹤0.01% 3495
2021
Q4
$138K Sell
43,654
-3,826
-8% -$12.1K ﹤0.01% 2908
2021
Q3
$156K Buy
47,480
+445
+0.9% +$1.46K ﹤0.01% 3081
2021
Q2
$198K Sell
47,035
-21,365
-31% -$89.9K ﹤0.01% 2899
2021
Q1
$341K Buy
68,400
+14,642
+27% +$73K ﹤0.01% 2879
2020
Q4
$680K Buy
53,758
+33,925
+171% +$429K ﹤0.01% 2174
2020
Q3
$195K Buy
19,833
+4,088
+26% +$40.2K ﹤0.01% 2760
2020
Q2
$156K Buy
15,745
+7,043
+81% +$69.8K ﹤0.01% 2935
2020
Q1
$76K Sell
8,702
-13,405
-61% -$117K ﹤0.01% 2935
2019
Q4
$204K Buy
22,107
+10,653
+93% +$98.3K ﹤0.01% 3162
2019
Q3
$67K Sell
11,454
-5,431
-32% -$31.8K ﹤0.01% 3588
2019
Q2
$203K Sell
16,885
-69,149
-80% -$831K ﹤0.01% 3186
2019
Q1
$1.04M Buy
86,034
+84,114
+4,381% +$1.02M ﹤0.01% 2119
2018
Q4
$25K Sell
1,920
-18,030
-90% -$235K ﹤0.01% 3334
2018
Q3
$297K Buy
19,950
+12,334
+162% +$184K ﹤0.01% 2882
2018
Q2
$129K Sell
7,616
-647
-8% -$11K ﹤0.01% 2960
2018
Q1
$189K Sell
8,263
-12,419
-60% -$284K ﹤0.01% 2863
2017
Q4
$534K Buy
20,682
+12,700
+159% +$328K ﹤0.01% 2048
2017
Q3
$118K Buy
7,982
+7,673
+2,483% +$113K ﹤0.01% 2639
2017
Q2
$4K Sell
309
-4,238
-93% -$54.9K ﹤0.01% 3598
2017
Q1
$78K Buy
4,547
+65
+1% +$1.12K ﹤0.01% 2941
2016
Q4
$46K Buy
4,482
+4,165
+1,314% +$42.7K ﹤0.01% 2868
2016
Q3
$3K Sell
317
-48
-13% -$454 ﹤0.01% 3545
2016
Q2
$4K Buy
365
+231
+172% +$2.53K ﹤0.01% 3175
2016
Q1
$1K Sell
134
-440
-77% -$3.28K ﹤0.01% 3361
2015
Q4
$10K Sell
574
-5,973
-91% -$104K ﹤0.01% 2819
2015
Q3
$117K Buy
6,547
+6,159
+1,587% +$110K ﹤0.01% 2319
2015
Q2
$5K Buy
388
+238
+159% +$3.07K ﹤0.01% 3630
2015
Q1
$2K Buy
+150
New +$2K ﹤0.01% 3932
2014
Q4
Sell
-72
Closed -$1K 4384
2014
Q3
$1K Sell
72
-20,441
-100% -$284K ﹤0.01% 4246
2014
Q2
$205K Buy
20,513
+14,542
+244% +$145K ﹤0.01% 2377
2014
Q1
$77K Buy
+5,971
New +$77K ﹤0.01% 2925